Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Porphyria-Inducing Drugs: Comparative Effects on Nuclear Ribonucleic Acid Polymerases in Rat Liver

HAROLD L. MOSES, THOMAS C. SPELSBERG, JOSEF KORINEK and FRANK CHYTIL
Molecular Pharmacology September 1976, 12 (5) 731-737;
HAROLD L. MOSES
Departments of Pathology and Molecular Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55901, and Departments of Pathology and Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
THOMAS C. SPELSBERG
Departments of Pathology and Molecular Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55901, and Departments of Pathology and Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JOSEF KORINEK
Departments of Pathology and Molecular Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55901, and Departments of Pathology and Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FRANK CHYTIL
Departments of Pathology and Molecular Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55901, and Departments of Pathology and Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Changes in δ-aminolevulinic acid (ALA) synthetase activity, endogenous nuclear RNA polymerase activities (nucleolar and nucleoplasmic), and the availability of chromatin DNA to serve as template for RNA synthesis in rat liver in response to treatment with two porphyria-producing compounds, allylisopropylacetamide (AIA) and 3,5-dicarbethoxy-1,4-dihydrocollidine (DDC), were determined. The alterations observed were compared with changes produced by two compounds that do not cause porphyria, phenobarbital (PB) and 3-methylcholanthrene (MC). Only AIA and DDC caused marked induction of ALA synthetase activity; PB caused a slight increase, and MC, no increase, in ALA synthetase. All four compounds caused some change in nuclear RNA synthesis in comparison with results in control animals given vehicle alone. AlA, DDC, and PB caused increased levels of RNA polymerase I (nucleolar) activity at time points later than 2 hr after injection, whereas MC resulted in a decreased level of RNA polymerase I activity at 8 and 12 hr. DDC, PB, and MC also caused prominent modulations in RNA polymerase II (nucleoplasmic) activity, the values 8 hr after injection being considerably greater than in control livers. An elevation in endogenous polymerase II activity persisted at 12 hr only in the DDC- and MC-treated animals. These alterations in polymerase II activity for the most part can be explained by changes in chromatin template capacity. DNA-dependent RNA synthesis using excess bacterial polymerase roughly paralleled the changes in polymerase II activity caused by DDC, PB, and MC treatment. Conversely, AIA caused only minimal changes in either polymerase II or chromatin template capacity. These data and those from other laboratories suggest that AIA and DDC may have different primary sites of action in the induction of excessive quantities of ALA synthetase, the first and rate-limiting enzyme in heme biosynthesis.

  • Copyright © 1976 by Academic Press, Inc.

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 12, Issue 5
1 Sep 1976
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Porphyria-Inducing Drugs: Comparative Effects on Nuclear Ribonucleic Acid Polymerases in Rat Liver
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Porphyria-Inducing Drugs: Comparative Effects on Nuclear Ribonucleic Acid Polymerases in Rat Liver

HAROLD L. MOSES, THOMAS C. SPELSBERG, JOSEF KORINEK and FRANK CHYTIL
Molecular Pharmacology September 1, 1976, 12 (5) 731-737;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Porphyria-Inducing Drugs: Comparative Effects on Nuclear Ribonucleic Acid Polymerases in Rat Liver

HAROLD L. MOSES, THOMAS C. SPELSBERG, JOSEF KORINEK and FRANK CHYTIL
Molecular Pharmacology September 1, 1976, 12 (5) 731-737;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Mechanism of the selective action of paraherquamide A
  • Fatty Acid Amide Hydrolase in Cisplatin Nephrotoxicity
  • Use-Dependent Relief of A-887826 Inhibition
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics